A key feature to the dimeric structure for the GrpE heat shock protein is the pair of long helices at the NH,-terminal end followed by a presumable extended segment of about 30 amino acids from each monomer. We have constructed a GrpE deletion mutant protein that contains only the unique tail portion (GrpEl-89) and another that is missing this region . Circular dichroism analysis shows that the GrpEl-89 mutant still contains one-third percent a-helical secondary structure. Using an assay that measures bound peptide to DnaK we show that the GrpEl-89 is able to lower the amount of bound peptide, whereas GrpE88197 has no effect. Additionally, when the same peptide binding assay is carried out with the COON-terminal domain of DnaK, the full-length GrpE and the two GrpE deletion mutants show little to no effect on peptide release. Furthermore, the GrpE88-197 mutant is able to enhance the off-rate of nucleotide from DnaK and the 1-89 mutant has no effect on the nucleotide release. Similar results of nucleotide release are observed with the NH,-terminal ATPase domain mutant of DnaK. The results presented show directly that there is interaction between the GrpE protein's "tail" region and the substrate COOH-terminal peptide binding domain of DnaK, although the effect is only fully manifest with an intact full-length DnaK molecule.
shock proteins have been shown to possess eukaryotic homologues (7) ; with some being recently identified in plants (8) . Much interest has been given to further the understanding of the mechanism by which DnaJ and GrpE regulate DnaK'S weak ATPase activity and how the ATP hydrolysis is coupled to the molecular chaperone activities (9-13).
Harrison and co-workers (14) determined the crystal structure of the GrpE-DnaK ATPase domain complex and found that a dimer of GrpE interacts in an asymmetric fashion with the DnaK ATPase domain. The crystal structure showed that a proteolytic fragment of GrpE (missing 33 residues from the NH,-terminal) exists as a homodimer composed of two long a-helices that run together in the same plane, followed by a loop and a short a-helix that come together to form a fourhelix bundle. At the COON-terminal end of each there is a small j3-domain made up of 6 (3-strands. An interesting and unique feature to GrpE's structure is the long a-helical region or "tail" that contains a stretch of amino acids at the end that is presumably flexible and in an extended conformation.
Previous research with GrpE, as related to its influence on DnaK's substrate binding domain has shown that it can cause an increase in the Ka for the peptidestimulated DnaK ATPase activity (9) . Furthermore, it has also been shown that GrpE causes the dissociation of the luciferase substrate (15) and it promotes the release of bound peptide (12) . It has been suggested that the NH,-terminal portion of GrpE that contains the long a-helix region and the flexible segment interacts with the peptide binding domain of DnaK (14) . In this report, we describe the construction of two deletion mutants of GrpE, one containing only the NH2terminal tail region and another mutant missing this portion. We demonstrate directly that the mutant containing the tail is able to release bound peptide from DnaK and the other is unable to release any peptide. The mutant missing the tail is still able to release bound nucleotide whereas the tail mutant has no effect on bound nucleotide. Additionally, the peptide releasing effect of GrpE can only be observed when both the N112-terminal ATPase domain and the COOHterminal substrate binding domains are together in an intact protein.
MATERIALS AND METHODS
Reagents and materials. Reagents and materials and their sources were Affi-Gel Blue Gel resin (Bio-Rad); ATP' (C-8 linkage) (Sigma); Mono-Q HR 10/10 and Superdex 75 HR 10/30 FPLC columns (Pharmacia Biotech); restriction enzymes and T4 DNA ligase (New England Biolabs); Amplitaq DNA polymerase (Perkin-Elmer); 12-to 14-kDa MWCO dialysis membrane (Spectra-Por); [3'S]ATPyB (12.5 mCi/mmol), and [a-`S]dATP (1.27 mCi/mmol) (NEN); Bio-Safe II scintillation cocktail (RPI); stirred cell concentrator and PM-10 and PM-30 membranes (Amicon); and nitrocellulose filters (type HA, 0.45 pm pore size) (Millipore). 3H-labeled PeptideC (KLIGVLSSLFRPK) was a gift from Roger McMacken and Robert Jordan and was prepared by solid-phase synthesis, purified by reverse-phase chromatography, and then labeled with tritium using reductive methylation. All other biochemicals were from Sigma.
Buffers and media. Buffer A is 25 mM Hepes/KOH, pH 7.6, 0.1 mM EDTA, 2 mM DTT, and 0.1 M NaCl; buffer B is 10 mM imidazole/HCI, pH 6.8, 1 mM DTT, 1 mM EDTA, 10 mM magnesium sulfate, 10% (v/v) glycerol; buffer T is 25 mM Hepes/KOH, pH 7.6, 0.5 mM EDTA, 1 mM DTT, and 10% (v/v) glycerol. SDS-PAGE sample buffer is 188 mM Tris-HCI, pH 6.8, 10% (3-mercaptoethanol, 0.01 mM bromphenol blue, 30% (v/v) glycerol. LB broth was prepared as described (16) .
Determination of protein concentration. The concentration of the purified proteins (except DnaK) were determined by the method of Bradford (17), using bovine y-globulin as a standard. The concentration of DnaK was determined using the calculated molar extinction coefficient of the native protein, 15,800 M-' cm-'. The molar protein concentration of full-length GrpE and all the mutants described in this paper are based on the molar mass of the monomeric form of the protein determined from the known amino acid sequence: wild type GrpE, 21,668; DnaKl-388 41,992; DnaK387-638 27,224; GrpEl-89 10,211; GrpE88-197, 11,733.
Strains and plasmids. Strain RLM 988 (C600dnaK103) was used for the expression of full-length GrpE and the two deletion mutants of DnaK. Strain RLM 569 (C600, recA, hsdR, tonA, lac -, pro-, leu-, thr', dnaJ') was used for the expression of the GrpEl-89 and GrpE89-197 deletion mutants. Plasmid pMOB45 dnaK' was used for the template DNA in the PCR described below for the construction of the DnaK mutants. Plasmid pRLM 156 was used as the expression vector for all proteins described in this paper. This plasmid is the same as pRLM76 (5) only it has a more versatile polylinker region for cloning purposes.
Plasmids carrying the appropriate dnah deletion mutant genes were constructed by cloning a DNA fragment produced by PCR mediated amplification using the plasmid pMOB45dnak+ DNA as the template and appropriate synthetic oligonucleotide primers. Briefly, the forward primer (oligonucleotide A was 5'-CCACCGGATCCAGGAGGA-TATATTAATGGGTAAAATAATTGGTATC-3') for the amplification of DNA for the cloning of the NH,-terminal domain contained a BamHI 'Abbreviations used: ATP, adenosine 5'-triphosphate; PCR, polymerase chain reaction; LB, Luria-Bertani broth; PMSF, phenylmethylsulfonyl fluoride; Hepes, N-2-hydroxyethylpiperazineN'-2-ethane sulfonic acid; DTT, dithiothreitol; ATP, Adenosine 5'-triphosphate; ADP, Adenosine 5'-diphosphate; ATP,/S, adenosine-5'-O-C3-thiotriphosphate; DEAE, diethylaminoethyl; EDTA, ethylenediamine tetraacetic acid.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH CO,MMUNTCATTONS recognition site and a consensus ribosome binding site juxtaposed to a coding sequence for the first six amino acids (underlined segment). The reverse primer (oligonucleotide B, 5'-CCGCAGTCGAGGGTACCC-CCGGGCTATTAGTCTTTTACGTCACCAGT-3') contained aXhoI recognition site, the complement of two tandem translation stop codons, and the complement of dnah coding sequence ending at amino acid 388. PCR amplification was performed in a reaction mixture (100 pd) containing 20 ng of template plasmid DNA, 100 pmol each of the forward and reverse primers, 50 pM each of the four dNTPs, 10 mM Tris-HCl, pH 8.3, 50 mM KCI, 1.5 mM MgClz, 0.01% gelatin, and 2.5 units of Amplitaq DNA polymerase. The PCR fragment was digested with BamHI and XhoI and ligated to pRLM156 which had been similarly digested. The newly created plasmid was named pRLM1157. Likewise, the DNA sequence coding for amino acids 387 through 638 (the COOHterminal domain) was amplified using PCR techniques. The forward primer used was oligonucleotide C, 5'-CCACCGGATCCAGGAGGAT-ATATTAATGAAAGACGTACTGCTGCTGGAC-3'. The reverse primer used was oligonucleotide D, 5'-CCGCACTCGAGGGTACCCCCG-GGCTATTATTTTTTGTCTTTGACT-3'. The PCR fragment was ligated into plasmid pRLM156 using the BamHI site for the 5' end and then the 3' end was blunt ended; thus created plasmid pRLM158. Ampicillinresistant clones were selected at 30°C and screened for their capacity to overproduce a polypeptide of appropriate size when grown at 42°C.
Plasmid carrying the wild type grpE gene was constructed by cloning a DNA fragment produced by PCR amplification of E. coli genomic DNA using appropriate synthetic oligonucleotides as primers. The sequence for the forward primer, oligonucleotide E, was 5'-CCACCGTCGACAAGAGGAGGATATATTAATGAGTAGTAAAGAACA-3'. Oligonucleotide E contained a Sall restriction site, a consensus ribosome binding site, an ATG initiation codon, and the grpE coding sequence (underlined above). The sequence of the reverse primer, oligonucleotide F, was 5'-CCACGGCGCCCTGCAG-GTATACCTATTAAGCTTTTGCTTTCGCTAC-3'. Oligonucleotide F contained a PstI restriction site, two tandem translation stop codons, and the complement of the grpE coding sequence (underlined). The amplified DNA fragment was digested to completion with Sall and PstI, and ligated to pRLM156 which had been similarly digested. DNA from the ligation reaction was transformed into RLM 988, and ampicillin-resistant clones were screened for the ability to overproduce a polypeptide the size of GrpE when grown at 42°C. The resulting plasmid was named pRLM159, and the strain was named RLM1183.
Plasmids carrying grpE deletion mutants were constructed in the same manner as for the wild-type grpE gene. E. coli genomic DNA was used for the template in the PCR and a new reverse primer (oligonucleotide G, 5'-CCACGGCGCCCCTGCAGGTATACCTATTA-CAGCGCGAATTTGTGGGC-3') was utilized with construction of GrpEl-89 and a new forward primer (oligonucleotide H, 5'-CCACCGTCGACAAGAAGGAGATATATTAATGCTGGAGAAATT-CATCAA-3'was utilized in the construction of GrpE88-197. The new reverse primer contained a PstI restriction site, two tandem translation stop codons, and the complement of grpE coding sequence (underlined above). The new forward primer contained a Sall restriction site, a consensus ribosome binding site, an ATG initiation codon, and the appropriate coding sequence (underlined above). The PCR amplification reaction used the same conditions as above. In each mutant the amplified DNA fragment was digested to completion with Sall and PstI, and ligated to pRLM156 which had been similarly digested. DNA from the ligation reaction was transformed into RLM 156, and ampicillin-resistant clones were screened for the ability to overproduce a protein of in the appropriate size range when grown at 42°C. A resulting plasmid was named pAFM8 for the 1-89 mutant and the strain was named AFM17. A resulting plasmid was named pAFM6 for the 88-197 mutant and the strain was named AFM9.
DNA sequencing. The dnah gene regions in pRLM157 and pRLM158, the grpE region of pRLM159, the grpE region coding for amino acid sequence 1-89 of AFM17, and grpE region coding for amino acid sequence 88-197 of AFM9 were sequenced on both strands using the dideoxynucleotide chain termination method with modified T7 DNA polymerase (Sequenase) as described by the manufacturer (U.S. Biochemical). All were found to contain the correct nucleotide sequences.
Expression and purification of the NHz-terminal domain of DnaK E. coli strain RLM 988 was transformed with plasmid pRLM 157 and grown in 1 liter of LB media at 30°C to an A;95 ",, of 1.5. The culture was then transferred to 42°C for 4 h and grown to and A595 "", of 3.5. Cells were harvested and suspended in buffer A (plus 100 mM PMSF). Lysis was achieved by adding 1 mg/ml lysozyme and incubating on ice for 30 min. Cell debris was pelleted by ultracentrifugation at 40K for 1 h. The ammonium sulfate pellet obtained with 75% (w/w) saturation was dialyzed against 2 liters of buffer B. This sample was loaded onto an ATP agarose resin (Sigma-type 3) and washed with 2 column volumes of buffer B, followed by 2 column volumes of 2 M KCl (buffer B) and then 0 M KCl (buffer B, 2 column volumes). The NH,-terminal domain was eluted from the column with 5 mM ATP (buffer B). The fractions containing the NHzterminal domain of DnaK were pooled, concentrated, and equilibrated in buffer T. This sample was loaded onto a Mono Q 10/10 (Pharmacia) column previously equilibrated in buffer T. The column was washed with 10 ml of buffer T and the NH,-terminal was eluted with a 110-ml gradient of 0 to 0.35 M NaCl at a flow rate of 1 ml/min. The NH,-terminal domain eluted at 0.25 M NaCl as determined by analysis with SDS-PAGE.
Expression and purification of the COOH-terminal domain of DnaK E. coli strain RLM 988 was transformed with plasmid pRLM 158 and grow in 1 liter of LB media (100 mg/ml ampicillin) at 30°C to an A.95 "R, of 1.6, after which the culture was transferred to 42°C and grown for 4 h giving a final A59; "," of 4.3. The cells were harvested by centrifugation for 10 min at 5000 rpm in a GSA rotor. The pellet of cells was suspended in 6 ml of buffer A to which PMSF (100 mM final) and MgC12 (10 mM final) were added. Lysis was achieved by the addition of 1 mg/ml lysozyme and subsequent quick freezing (liquid Nz) and thawing. Cell debris was pelleted by ultracentrifi4gation at 40K for 1 h. Ammonium sulfate was added with stirring to give 80% (w/w) saturation. The suspension was centrifuged at lOK for 40 min. This pellet was suspended in 5 ml buffer T and the dialyzed overnight against 2 liters of buffer T. This supernatant was loaded onto a DEAE Sephacel column previously equilibrated with buffer T. The resin was washed once with 1 column volume of buffer T and then a linear gradient of 0 to 0.5 M KCl (buffer T) was run to elute the protein. Fractions were monitored for protein content by analysis with SDS-PAGE of each fraction. The COOH-terminal domain eluted at approximately 0.25 M KCl. The fractions containing the COOH-terminal domain were pooled, concentrated, and equilibrated in buffer T. This sample was loaded onto an Affi-gel Blue column previously equilibrated with buffer T. The resin was washed with 2 column volumes of buffer T and then with 2 column volumes of 2 M NaCl (buffer T). The COOH-terminal domain was found in the flow through fractions. The fractions containing the COOH-terminal domain were pooled, concentrated, and equilibrated in buffer T. This sample was loaded onto a Q-Sepharose column previously equilibrated with buffer T. The resin was washed with one column volume of buffer T followed by a linear gradient of 0 to 0.5 M KCl (buffer T, 6 column volumes total volume). The COOH-terminal domain eluted as a broad peak starting at 0.3 M KCl. Fractions from the gradient showing the highest amount of purity as determined by SDS-PAGE were pooled, concentrated and equilibrated in buffer T. Although the fraction from the Q-Sepharose step shows high purity we found that this fraction contained a small amount of ATPase activity. This contaminating ATPase activity was removed by using a Mono P (FPLC-Pharmacia) column. The Mono P (5/5) column was equilibrated with 25 mM Bis Tr1S/HCI, pH 6.7. Protein from the Q-Sepharose fraction (2 mg) was applied to the column and washed with 4 ml of start buffer. A pH gradient was run from pH 6.0 to 4.0 using Polybuffer 74 at a flow rate of 0.5 ml/min. The COOH-terminal domain eluted at pH 5.0. Fractions containing BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS the COOH-terminal domain were pooled, concentrated, and equilibrated in buffer T.
Expression and purification of GrpE. E. coli cells carrying pRLM159
were grown aerobically at 30°C in 1 liter of LB broth to an optical density of 1.3 at 595 run. Cells were then transferred to 42°C and grown an additional 4 h. Cell density typically was 3.2 at 595 ran after this induction period. Cells were harvested by centrifugation and then the pellet was suspended in 10 ml of buffer A. Cell lysis was achieved by the addition of lysozyme to a final concentration of 1.0 mg/ml and then incubated at room temperature for 30 min. All subsequent steps were carried out at 0-4°C. Cell debris was removed by centrifugation for 60 min at 17,000 rpm in a Beckman SS34 rotor (35,OOOg). To the supernatant, ammonium sulfate was slowly added to 55% saturation (0.351 g of ammonium sulfate/ml of supernatant) and then stirred for additional 30 min. The precipitate that formed was removed by centrifugation for 60 min at 12,000 rpm in a Beckman SS34 rotor (17,OOOg). The pelleted precipitate was resuspended in 3.0 ml of buffer T and then dialyzed for 16 h against 2 liters of buffer T. The dialyzed protein was applied to a DEAF cellulose column (2.5 X 10 cm) that had been equilibrated with buffer T. Column was washed with 20 ml of buffer T and then a 200-ml linear gradient of 0.0-0.5 M NaCl was run to elute the bound proteins. The peak GrpE-containing fractions (0.40 M NaCl) were pooled and concentrated in buffer T. The concentrated protein sample was applied to an Affi-gel Blue column (2.5 X 14 cm) previously equilibrated with buffer T. The resin was washed with 150 ml of buffer T to elute the GrpE protein (found in flow-through fractions). The fractions containing the GrpE protein were pooled, concentrated, and equilibrated in buffer T. This sample was loaded onto a Mono Q (Pharmacia 10/10) column previously equilibrated in buffer T. The column was washed with 10 ml of buffer T and then with 10 ml of 0.25 M NaCl (buffer T). A gradient (total volume 100 ml was then run from 0.25 to 0.5 M NaCl at a flow rate of 1 ml/min and the GrpE protein eluted at 0.31 M NaCl as determined by SDS-PAGE. This protocol gives a yield of approximately 23 mg of GrpE protein from 1.0 liter of LB media at greater than 95% purity.
Expression and purification of GrpEl-89. Cells carrying pAFM17 were grown, thermally induced, harvested, and lysed, and an ammonium sulfate pellet was formed at 55% saturation as described above for wild type GrpE. The pelleted precipitate was resuspended in 3.0 ml of buffer T and then dialyzed for 16 h against 2 liters of buffer T. The concentrated protein sample was applied to an Affi-gel Blue column (2.5 X 14 cm) previously equilibrated with buffer T. The resin was washed with 200 ml of buffer T. The GrpEl-89 containing fractions (elution happened immediately after the void volume) were pooled, concentrated, and equilibrated in buffer T. The concentrated protein was applied to a DEAF cellulose column (2.5 X 10 cm) that had been equilibrated with buffer T. The column was washed with 20 ml of buffer T and then a 400-ml linear gradient of 0.0-0.5 M NaCl was run to elute the bound GrpEl-89 mutant protein. After concentration and equilibration in buffer T, this protein fraction was loaded onto a Mono Q (Pharmacia 10/10) column previously equilibrated in buffer T. The column was washed with 36 ml of buffer T and then a gradient (total volume 120 ml was then run from 0.0 to 0.4 M NaCl at a flow rate of 2 ml/min. The GrpEl-89 mutant protein eluted at 0.23 M NaCI as determined by SDS-PAGE. . Cells carrying pAFM9 were grown, thermally induced, harvested, and lysed, and an ammonium sulfate pellet was formed at 55% saturation as described above for wild-type GrpE. The pelleted precipitate was resuspended in 3.0 ml of buffer T and then dialyzed for 16 h against 2 liters of buffer T. The concentrated protein sample was applied to an Affi-gel Blue column (2.5 X 14 cm) previously equilibrated with buffer T. The resin was washed with 100 ml of buffer T and then a 400-ml linear gradient of 0.0-1.0 M NaCl was run to elute the bound mutant protein. . A ribbon diagram depicts the structure for the GrpE dimer. The structure is based on the X-ray crystallographic data determined for a deletion mutant of GrpE that is missing the first 33 amino acids on the NH,-terminal end and is in a complex with the ATPase domain of DnaK (6) . The three regions of the protein are labeled by color: the NHZ-terminal a-helical "tail" portion composed of amino acids 34-89 from each monomer (yellow), the four-helix bundle motif composed of amino acids 90-138 from each monomer (red), and the COOH-terminal (3-sheet domain composed of amino acids 139-197 from each monomer (blue). The image was created using WebLab Viewer Pro 3.7.
Expression and purification of
was applied to a DEAF cellulose column (2.5 x 10 cm) that had been equilibrated with buffer T. The column was washed with 20 ml of buffer T and then a 400-ml linear gradient of 0.0-0.5 M NaCl was run to elute the bound GrpE89-197 mutant protein. The peak of GrpE88-197-containing fractions (0.40 M Nan) were pooled and concentrated in buffer T. This sample was loaded onto a Mono Q (Pharmacia 10/10) column previously equilibrated in buffer T. The column was washed with 36 ml of buffer T and then a gradient (total volume 120 ml was then run from 0.0 to 0.4 M NaCl at a flow rate of 2 ml/min. The GrpE88-197 mutant protein eluted at two points in the gradient, one at 0.10 M NaCl and the other at 0.17 M NaCl as determined by SDS-PAGE.
Expression and purification of DnaK. DnaK was purified as described elsewhere (18).
Circular dichroism (CD) spectroscopy. CD analysis was carried out at the University of Illinois Champaign-Urbana's Laboratory for Fluorescence Dynamics. CD spectra were recorded at 20°C on a Jasco Model 720 instrument in a 2.0-mm-pathlength cell. Proteins in 20 mM potassium phosphate buffer (pH 7.0), 1 mM DTT, 5.0 MM MgC12, 25.0 mM KCI, and 10% (v/v) glycerol were used at concentrations of 30 p M. Data were collected with a scanning rate of 50 nm min-' with 0.5 nm intervals at a spectral band width of 1.0 rim. Mean residue molar ellipticity was calculated as described (19) .
Assay to monitor PeptideC binding to DnaK and the COOHterminal domain of DnaK DnaK (7 [LM) or DnaK387-638 (4 pM) was incubated at
22°C for 10 min with 3H-labeled PeptideC (at a concentration much lower to achieve maximum binding) in buffer containing 25 mM Hepes at pH 7.6 and 100 mM KCI. Wild-type GrpE or the GrpE deletion mutants were then added at various concentrations as indicated for 25 min at 22°C. Samples were then analyzed for amount of bound PeptideC using gel filtration chromatography. A 50-p1 aliquot was loaded onto a Superdex 75 column previously equilibrated with 100 mM NaKP04, pH 7.6, and 10% (v/v) glycerol. Elution of bound PeptideC and free PeptideC was obtained using the same buffer at a flow rate of 0.4 ml/min. Fractions that contained the bound PeptideC and the free Pep-tideC were analyzed and for radioactivity using scintillation techniques.
Pulse-chase experiments to determine the off-rate of f'SS)ATP-YS from DnaK and the NH,-terminal ATPase domain of DnaK DnaK (2.0 AM) or
DnaKl-388 (2.0 AM), in the presence of either wild-type GrpE or the GrpE deletion mutants, was preincubated with 3.5 nM [35S]ATPyS (the pulse, S. A. 12.5 mCi/mmol) for 10 min at RT in a solution that contained 40 mM Hepes/KOH, pH 7.6, 11 mM magnesium acetate, and 0.1 M potassium glutamate. The chase (ATPyS, 1.75 mM final) was then added and aliquots were taken at specified times and run through a nitrocellulose filter (0.45 AM) and washed once with 1 ml of buffer T. Filters were then dried and the amount of retained radioactivity was determined using scintillation techniques.
RESULTS

Expression and Purification of GrpE, GrpEl-89, and
GrpE88-197 Proteins
Based on the known crystal structure for the proteolytic fragment of GrpE (14) (see Fig. 1 ) in a complex with DnaK, we designed two deletion mutant proteins of GrpE. One (GrpEl-89) was constructed to encompass only the long a-helical tail plus a presumably flexible portion that has an extended conformation at the NH,-terminal end. The other mutant (GrpE88-197) constructed is missing this unique NH,-terminal structure and thus contains the two short a-helices (amino acids 88-138) that contribute to the 4 helix bundle in the dimer and a (3-sheet domain (amino acids 138197). Figure 2 shows the final purified wild type GrpE and the two GrpE deletion mutant proteins. All proteins exhibited greater than 95% purity as determined by densitometry. All the proteins were purified by similar means (see Materials and Methods). One interesting difference with the purification of GrpE88-197 is that it showed strong affinity for the Affi-Gel Blue resin as opposed to the weak affinity exhibited by wild-type GrpE and GrpEl-89. Another difference exhibited in the purification of GrpE88-197 is that it elutes at two distinct points in the salt gradient of the Mono-Q purification step. Both of these positions of elution are before the amount of salt needed to elute full-length GrpE. GrpE88-197 that elutes at 0.17 M NaCl show higher purity and consequently the data collected in this paper are with this fraction.
Full-length GrpE protein travels in SDS-PAGE to a position that gives a higher molecular mass than is predicted by the calculated molar mass. Interestingly, GrpEl-89 has this same feature but GrpE88-197 does not. The GrpE88-197 protein travels to a position that is very close to its predicted molar mass. Analysis of the first 33 amino acids of GrpE revealed that the ratio of negatively charged amino acids to positively charged amino acids is about 5:1. This high ratio could explain the migration patterns for full-length GrpE and GrpE 1-89 plus the difference in affinity toward the Affi-Gel Blue resin. Other GrpE deletion mutant pro- teins containing or missing the first 33 amino acids also show this behavior (data not shown).
Expression and Purification DnaKl-388 and DnaK387-638 Proteins
The final purified DnaK mutants are shown in Fig. 2 . The purification of the NHZ-terminal ATPase Domain utilized the same chromatographic steps that was used in the purification of the full-length protein. The purification of the COOH-terminal substrate binding domain was much more difficult, requiring a number of different chromatographic resins. Other researchers have utilized these mutants of DnaK (21) or HSC70 (24) for various studies.
Circular Dachroism Spectroscopy of GrpE and the
GrpE Deletion Mutants
Protein secondary structural content of full-length GrpE and the two deletion mutants was probed for by CD spectroscopy. As shown in Fig. 3 , full-length GrpE gives a spectrum that exhibits a large amount of a-helical secondary structure. Using software that analyzes protein CD spectra (20) for a-helical and /3-strand segments, the spectrum for the full-length protein gave 80% a-helical. The GrpE88-197 also shows a large amount of a-helical content; this result is expected since the helices that form the four-helix bundle are still intact (see Fig. 3 ). The spectrum for the GrpE 1-89 mutant looks different from the full-length and GrpE88-197 spectra, and clearly there is less a-helical content with this mutant. The spectrum for the GrpEl-89 does have some a-helical content (36% when analyzed), however, and does not indicate that the mutant is completely unfolded and in a random-coil conformation.
Capacity of GrpE and the GrpE Deletion Mutants to Decrease the Amount of Bound Substrate from DnaK or the COOH-Terminal Domain of D>zaK
To test directly the proposed idea that the NH, terminal region of GrpE with the long a-helical tail and flexible end interacts with the substrate binding domain of DnaK, we measured the ability of the BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS GrpEI-89 mutant to decrease the amount of bound PeptideC. PeptideC has previously been shown to modulate the ATPase activity of DnaK (9) . As shown in Fig. 4A , the GrpEI-89 mutant is able to decrease the amount of DnaK-bound PeptideC. However, when compared to full-length GrpE the GrpEl-89 is not as efficient. An approximately 3.5-fold increase in concentration is needed by GrpE 1-89 to achieve that same decrease in DnaK-bound PeptideC as that of fulllength GrpE. The GrpE88-197 mutant was unable to cause a decrease in the amount of DnaK-bound PeptideC. These results are consistent with the previously reported finding that a GrpE mutant containing amino acids 34-197 is unable to cause dissociation between DnaK and carboxymethylated a-lactalbumin (14) . The concentrations of GrpE are higher that those observed with the dissociation of carboxymethylated a-lactalbumin (14); it could be that PepC shows a higher affinity for DnaK, and thus would need more GrpE to cause dissociation. Adding the GrpE88-197 mutant to the GrpEl-89 mutant did not increase the amount of peptide release (data riot shown). When the same experiment was carried out with the COON-terminal substrate binding domain of DnaK (see Fig.  4B ), we see that GrpE and the GrpE88-197 mutant have no effect on the release of bound PepC. However, the GrpE1-89 mutant shows a very small effect compared to its effect on the release of bound PepC from full-length DnaK. This result points to the fact that the GrpE1-89 mutant may not be adopting the exact NH2-terminal tail structure as is found in the crystal structure. Thus, to a certain extent, competes with the PeptideC substrate because it has an extended structure, irrespective of whether it is the exact same shape as is found in nature.
Capacity of GrpE and the GrpE Deletion Mutants to Stimulate the Nucleotide Off-Rate from DnaK or the NH,-Terminal ATPase Domain of DnaK
To verify that the GrpE88-197 mutant protein still has the ability to interact with DnaK at the ATPase domain and to find out if GrpEl-89 is able to interact with the ATPase domain we tested these mutants for the capacity to enhance the nucleotide off-rate from DnaK (both the full-length form and the isolated NHzterminal ATPase domain). As illustrated in Fig. 5A , the GrpE88-198 mutant is able to increase the off-rate BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS from DnaK; the amount of mutant needed, however is approximately 5-to 10-fold higher than that for wildtype GrpE. The concentrations of wild-type GrpE and GrpE88-197 are not saturating conditions and are much lower then the concentrations used by Packschies and co-workers (10); and thus these off-rates are much slower then those reported using the fluorescent nucleotide analog and monitoring a change in fluorescence (10) . The purpose of these experiments was to identify capacities of GrpE mutants. Also shown in Fig. 5 are the results when GrpEl-89 was tested for any capacity to stimulate nucleotide off-rate. Little or no effect is seen with this mutant at a concentration equal to that of GrpE88-197. Similar results were obtained when the ATPase domain of DnaK was utilized (see Fig. 5B ). We have also observed that there is no stimulation of nucleotide off-rate from other GrpE mutant such as GrpEl-142 and GrpEl-169 and both of these mutant show CD spectra that are almost identical to full-length GrpE.4
DISCUSSION
Research within the past 5-10 years on the GrpE heat shock protein has focused primarily on the role of GrpE in the DnaK chaperone mediated interaction with polypeptide substrates. It is well documented that one function of GrpE is to act as a "nucleotide exchange factor" in regulating the weak intrinsic ATPase activity of DnaK by increasing the off-rate of ADP during the binding and releasing of substrates by DnaK (1012, 15, 21, 22) . The partial structure for GrpE in a complex with the ATPase domain of DnaK was elucidated and mechanism by which GrpE promotes nucleotide release was established (14) . Currently, a new interest in GrpE has arisen. The dimeric structure for GrpE shows a very unusual and unique structural feature in that the paired NHZ-terminal ends from each monomer form a very long tail. Each monomer contributes two parts to this tail. One part is a presumably flexible and extended polypeptide tip of about 30 amino acids and the other part is the long a-helical region composed of about 60 amino acids. What is the function of this tail region? Earlier research on GrpE has hinted to the possible additional role for GrpE in the release of tightly bound substrates from DnaK. Szabo and co-workers (15) found that GrpE was able to release a portion of bound luciferase form a preformed DnaK-ADP/DnaJ complex. Also it was shown through spectroscopic techniques that GrpE was able to release peptide from a DnaK-DnaJ-peptide complex (12) . Additionally it was found that GrpE increased the Ka for a peptide stimulated ATPase activity of DnaK (9). Consequently, speculation for the role of the tail was presumed to be involved in assisting substrate release ' A. F. Mehl and T. Watanabe, unpublished results.
from DnaK. The results presented in this paper clearly shows that the GrpE tail region able to compete for the polypeptide substrate binding site of DnaK. If the GrpE 1-89 mutant protein was adopting a shape that has no resemblance to the tail region of GrpE then it could still compete with polypeptide substrate as an unfolded protein species. If this were the case than we would have expected the mutant to show similar behavior with both full-length DnaK and the COOHterminal domain of DnaK in the PeptideC release experiments. We see different results with the GrpEl-89 mutant, so there must be some similarity to the tail region. There is an increase in PeptideC release with full-length DnaK, indicating a protein-protein interaction that manifests itself in the interdomain communication within the DnaK protein. Some peptide substrates for DnaK show very high affinity (23) so that it is possible that GrpE not only promotes ADP release after hydrolysis, but also facilitates polypeptide release as well, at least in cases of tight binding substrates.
One could envision the flexible end of the GrpE protein with its extended structure interacting with the peptide binding pocket of DnaK. However, the structure for the binding domain shows a deep pocket lined with hydrophobic residues (24, 26) , and the flexible end of GrpE is composed almost entirely of charged and polar residues. Could the interaction be at a site distant from the peptide binding pocket? The results from the PepC release from the COOH-terminal domain suggest that for the efficient substrate release by GrpE there must be interdomain communication between the ATPase domain and the substrate binding domain of DnaK when GrpE interacts with DnaK. Interestingly, we have found that the GrpE 1-89 mutant is unable to form a dimer and thus it seems as if its interaction with DnaK involves a monomeric species.' This interaction is not unreasonable because GrpE is know to interact in an asymmetric fashion (14) , only using one monomer. From the results with this mutant in the assay for PepC release from the COON-terminal domain of DnaK, it would seem that there is a small amount of facilitated release that may not need interdomain communication within DnaK. Future work will involve mapping the specific location where the GrpE's tail interacts with DnaK's substrate binding domain.
Homologues of GrpE have been identified in the mitochondria of eukaryotes and chloroplasts of plants. More recently GrpE-like proteins have been found in mammalian cytosol (7) . It is becoming increasingly evident that GrpE plays an important role in assisting DnaK with its chaperone activities in major compartments of eukaryotic cells. Research into the interaction between GrpE and DnaK in all species must not only include the interaction with the NH,-terminal ATPase
